El-Mohandes Ayman, Herman Allen A, Nabil El-Khorazaty M, Katta Pragathi S, White Davene, Grylack Lawrence
George Washington University Medical Center, Washington, DC 20037, USA.
J Perinatol. 2003 Jul-Aug;23(5):354-60. doi: 10.1038/sj.jp.7210933.
To estimate the extent that prenatal care (PNC) retains its protective influence against prematurity, low birth weight (LBW), and small for gestational age (SGA) status in infants exposed to illicit drug use (IDU) in pregnancy.
This was a prospective cohort analysis including 6673 women residents of the District of Columbia (Washington, DC, USA) delivering at four city hospitals. Women were screened in the immediate postpartum period. Levels of PNC were established according to American College of Obstetrics and Gynecology guidelines and the Kotelchuck index. PNC and IDU were compared between subgroups. Adjusted relative risks for prematurity, LBW and SGA, controlling for maternal and gestational ages, were calculated in different groups according to IDU and level of PNC.
IDU was identified in 13% of mothers screened. PNC was classified as none (6%), inadequate (10%), intermediate (20%), and adequate (64%). The highest risk for prematurity, LBW, or SGA occurred in infants born to mothers with no PNC and positive IDU in pregnancy (prematurity OR=12.05, 95% CI: 8.99 to 16.16; LBW OR=14.76, 95% CI: 11.03 to 19.75; SGA OR=9.20, 95% CI: 5.32 to 15.92). As PNC levels increased, significant reductions in risk for prematurity and LBW (not for SGA) in IDU-exposed infants were observed. Risk for SGA in IDU-exposed infants reduced significantly when PNC was introduced.
In infants exposed to IDU, a reduction in risk for prematurity, LBW, and SGA, was consistently demonstrated with improved levels of PNC. In high-risk populations, health care should seek to reach mothers early, especially those identified at risk for IDU, and deliver PNC to them effectively.
评估孕期接受产前护理(PNC)对孕期使用非法药物(IDU)的婴儿预防早产、低出生体重(LBW)和小于胎龄儿(SGA)状况的保护作用程度。
这是一项前瞻性队列分析,纳入了在美国华盛顿特区四家城市医院分娩的6673名哥伦比亚特区女性居民。在产后即刻对女性进行筛查。根据美国妇产科医师学会指南和科特尔查克指数确定PNC水平。比较各亚组之间的PNC和IDU情况。根据IDU和PNC水平,在不同组中计算调整后的早产、低出生体重和小于胎龄儿的相对风险,并对产妇年龄和孕周进行控制。
在接受筛查的母亲中,13%被确定为孕期使用非法药物。PNC被分类为无(6%)、不足(10%)、中等(20%)和充足(64%)。早产、低出生体重或小于胎龄儿的最高风险发生在孕期未接受PNC且使用非法药物呈阳性的母亲所生的婴儿中(早产OR = 12.05,95%可信区间:8.99至16.16;低出生体重OR = 14.76,95%可信区间:11.03至19.75;小于胎龄儿OR = 9.20,95%可信区间:5.32至15.92)。随着PNC水平的提高,观察到孕期使用非法药物婴儿的早产和低出生体重风险显著降低(小于胎龄儿风险未降低)。当引入PNC时,孕期使用非法药物婴儿的小于胎龄儿风险显著降低。
在孕期使用非法药物的婴儿中,PNC水平的提高持续显示出早产、低出生体重和小于胎龄儿风险的降低。在高危人群中,医疗保健应尽早接触母亲,尤其是那些被确定有孕期使用非法药物风险的母亲,并有效地为她们提供产前护理。